相关实验视频
Updated: Sep 12, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
349
对患者体验的定性分析使用塞马格卢提德2.4毫克减肥
Eion Plenn1, Dylan Amin2, Jonathan Henry3
1Penn State College of Medicine Hershey Pennsylvania USA.
Obesity science & practice
|August 7, 2025
概括
在现实世界中,Semaglutide 2.4 mg (Wegovy) 的用户报告了显著的减肥效果和心理社会益处. 了解这些经验对于优化使用第二代药物治疗肥胖症的关键.
科学领域:
- 肥胖医学 肥胖医学
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 塞马格卢提德2.4毫克 (Wegovy) 是第二代领先的抗肥胖药物.
- 了解真实世界的患者体验是至关重要的,因为它的有效性和药物短缺.
研究的目的:
- 为了探索塞马格卢提德2.4毫克用于体重管理的用户叙述.
- 为了分析在Reddit上分享的体验.
主要方法:
- 来自r/WegovyWeightLoss (2022年10月至2023年10月) 的660个Reddit帖子的定性分析.
- 合作编码书开发和主题分析.
主要成果:
- 主要主题:药物疗效 (29.4%),心理社会影响 (22.8%),副作用 (13.3%),进入障碍 (10.7%),生活方式变化 (10.2%),社区支持 (9.2%) 和耻辱 (4.4%).
结论:
- 雷迪特的帖子提供了对现实世界塞马格卢提德2.4毫克使用的见解.
- 这些发现可以为医疗保健提供者提供信息,帮助他们量身定制肥胖治疗和患者护理.
相关概念视频
01:17Assessment of the Gastrointestinal System I: Subjective Data
280
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
280
01:24Glucagon-like Receptor Agonists
419
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
419
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
162
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
162
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420